- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/38 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 333/38
Total number of patents in this class: 715
10-year publication summary
|
50
|
38
|
42
|
46
|
48
|
40
|
49
|
54
|
33
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2361 |
32 |
| Takeda Pharmaceutical Company Limited | 2708 |
28 |
| Bayer AG | 3308 |
23 |
| BASF SE | 20803 |
10 |
| Astellas Pharma Inc. | 1086 |
10 |
| AstraZeneca AB | 2933 |
9 |
| Nissan Chemical Industries, Ltd. | 1725 |
8 |
| Bayer Cropscience SA | 41 |
7 |
| EA Pharma Co., Ltd. | 86 |
7 |
| Boehringer Ingelheim International GmbH | 4698 |
6 |
| Bayer Cropscience AG | 2057 |
6 |
| Bayer Pharma AG | 1061 |
6 |
| Vertex Pharmaceuticals Incorporated | 1598 |
6 |
| Alcon, Inc. | 5394 |
6 |
| Global Blood Therapeutics, Inc. | 183 |
6 |
| Kissei Pharmaceutical Co., Ltd. | 184 |
6 |
| Corteva Agriscience LLC | 2660 |
6 |
| Xwpharma Ltd. | 57 |
6 |
| Activesite Pharmaceuticals, Inc. | 19 |
5 |
| Novartis AG | 10883 |
4 |
| Other owners | 518 |